Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy associated to severe ADAMTS13 deficiency. It has been linked to various viral infections. Among arboviruses, only Crimean-Congo haemorrhagic fever and dengue fever have been linked to this severe disease. We report the first documented case of TTP concomitant to Chikungunya virus infection.
Introduction
Thrombotic microangiopathies (TMAs) represent a group of rare but life-threatening diseases, defined by microangiopathic haemolytic anaemia and thrombocytopenia, sometimes associated with visceral ischaemic manifestations. Among TMAs, thrombotic thrombocytopenic purpura (TTP) results from a deficiency of ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13), a metalloprotease involved in the regulation of the haemostatic properties of von Willebrand factor (VWF). 1 Predisposing factors have been described to explain the occurrence of TTP, such as pregnancy, autoimmune disorders, cancer, drug, bone marrow or solid organ transplantation and infections. 2 Bacterial, parasitic and viral infections have been described to be trigger factors in the pathogenesis of TMAs. To our knowledge, we report the first case of TTP concomitant to chikungunya virus infection.
Case Report
A previously healthy 43 years-old woman presented to the emergency room of the Hospital of Cayenne, the main hospital of French Guiana, a French overseas region located on the Northeastern part of South America, with a 4 days fever, asthenia, dyspnea, frontal headache, diffuse myalgia and joint pain during the epidemics of chikungunya of 2014. She related no medical history, and was native from Haiti, living in French Guiana for 16 years. She had been treated with oral acetaminophen and diclofenac for 2 days. At admission, her body temperature was 37.8 C. Physical examination revealed petechial purpura on chest. Initial blood test showed: haemoglobin 7.3 g/dl, mean corpuscular volume 84 fL, platelet count 15 G/L, reticulocyte count 230 G/L, schizocyte count 3% (normal value <1%), leukocyte count 5.5 G/L, creatinine level 67 mmol/l, C-reactive protein 21.3 mg/l, normal prothrombin and activated partial thromboplastin time, ferritin 1472 IU/L, fibrinogen 4.14 g/l, normal aspartate and alanine aminotransferase levels, chorionic gonadotropin beta < 0.100 IU/L, total and conjugated bilirubin 41.1 and 12.5 mmol/l, respectively (normal < 15 and <3.4 mmol/l, respectively). Real-time Polymerase chain reaction was positive for chikungunya virus. Following results were negative: direct antiglobulin test, NS1 antigen and IgM for dengue virus, thick blood smear for malaria, serodiagnosis for Human Immunodeficiency Virus, hepatitis B and C virus, Human T leukemia virus (HTLV-1&2). Serodiagnosis for cytomegalovirus, Epstein Barr virus hepatitis A virus, and toxoplasmosis showed either prior immunity or immunization. Zika virus was not present yet in Latin America at that time and therefore was not tested. Antibody Tests for Autoimmune Disorders were negative (Anti-DNA, antinuclear, anti-beta 2 glycoprotein 1, lupus anticoagulant and anti-neutrophil cytoplasmic antibodies) and Plasma total haemolytic complement assay (CH50) was normal. ADAMTS13 activity was undetectable (< 5% of a normal plasma pool) and anti-ADAMTS13 IgG autoantibodies were detected. These latter tests were performed in the central laboratory of the National Reference Center for Thrombotic Microangiopathies (Lariboisière hospital, Paris, France). ADAMTS13 activity and ADAMTS13 autoantibodies measurements were realized according to the procedures described by Mariotte et al.
1
On day 2, she received red blood cells transfusions because haemoglobin rate dropped to 5.7 g/dl. Headaches decreased with simple painkillers, and the physicians were wrongly reassured by the patient's stable clinical state. On day 5, headaches worsened, confusion and transient facial paralysis occurred. Platelet count dropped and, schizocyte count increased (Table 1 ). Brain computed tomography scan without contrast was normal. Brain magnetic resonance imaging could not be performed due to the agitation of the patient. She received intravenous bolus of one gram of methylprednisolone and fresh frozen plasma (FFP) transfusions (30 ml/kg/day), since plasma exchange was not available in French Guiana. Despite this treatment, her neurological status worsened and she died on day 6 during sanitary evacuation to Martinique, French Caribbean, while the aircraft was landing.
Discussion
Chikungunya virus (CHIKV) is an arthropod-borne RNA virus belonging to the Alphavirus genus of the Togaviridae family. 3 In
French Guiana, the first reported CHIKV epidemic lasted from February 2014 to October 2015, with 16 000 estimated cases among 250 000 inhabitants. Symptoms are generally mild and self-limiting but severe forms have been described. 4 The TTP can lead to multivisceral ischaemic process with a frequent neurological involvement, sometimes severe. The diagnosis is confirmed by ADAMTS13 activity severe deficiency. In the French TMA national registry, this latter is mainly due to anti-ADAMTS13 IgG (75%), other unknown acquired mechanism (22%), or inherited mutations of the ADAMTS13 gene disease (Upshaw-Schulman syndrome) (3%).
1 Complex mechanisms including other platelet adherence regulating proteins and a genetic susceptibility have also been suspected in the physiopathology.
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The classical predisposing factors are pregnancy, autoimmune disorders, cancer, drug, bone marrow or solid organ transplantation. However, bacterial, parasitic and viral infections especially HIV, HTLV-1, hepatitis C virus, BK virus and Herpes viridae family such as Varicella-zoster virus, cytomegalovirus, HHV-6 and -8 have been described to be trigger factors in the pathogenesis of TMAs. 6, 7 Acute viral infections such as Coxsackie virus, echovirus, Influenza A, adenovirus and parvovirus B19 have also been incriminated. Arboviruses have been incriminated in TAMs before, especially CrimeanCongo haemorrhagic fever in HUS and dengue fever in HUS and TTP. [8] [9] [10] In the present case, the patient suffered from a confirmed acute CHIKV infection explaining for some of her clinical signs. She also developed neurological and haematological symptoms that were not previously described with CHIKV infection and were compatible with acquired TTP, also retrospectively confirmed. Tests for autoimmune diseases were negative. The chikungunya acute infection possibly triggered the development of an acquired TTP in this patient. Nevertheless, whether the two conditions were associated here, proving the causal link remains impossible.
Severe coagulopathies have been associated to chikungunya infection. 11 Those patients developed a severe skin necrosis and multiorgan failure which was not the case here. Elevated DDimer could suggest a disseminated intravascular coagulation, but this hypothesis was ruled out since other haemostasis tests (global tests and fibrinogen) remained normal and stable. Death during in-flight travel is not a common event on commercial airline flights. In a recent publication reviewing records of in-flight medical emergency calls from five domestic and international airlines from January 2008, to October 2010, 36 (0.3%) patients died among 10 914 passengers for whom postflight follow-up data were available. 12 Another study analysed travel-related deaths in travellers arriving in the United States from July 2005 to June 2008. 13 Among the 213 identified deaths, 81 were associated to air-travel, 77 occurred in passengers, 3 among air ambulance patients and 1 a stowaway. In the present case, logistical issues delayed the air medical evacuation to Martinique and therefore optimum treatment. In French Guiana, when patient's conditions are severe and hence need for specific care not available in our territory, a transfer is organized. Patients are exclusively transferred to mainland France and the French Caribbean (Martinique and Guadeloupe Islands) where both medical and technical resources are more developed. Unfortunately, these medical evacuations rely on domestic flights that are planned daily between French Guiana and Martinique (flight time 2 hours) or takes a long time with limited monitoring to mainland France (flight time 8-9 hours). Furthermore, medical material such as oxygen tank, is not available in every aircraft. That's why it was impossible for our patient to be evacuated to a specialized department where plasma exchange would be available, and that was probably a significant factor in the patient's death. It is to note that after that tragic medical history, plasma exchanges were implemented in our hospital.
To the best of our knowledge, this is the first description of acquired TTP associated with CHIKV infection. No differential diagnosis (neoplasia, infection, pregnancy or autoimmune disease) was found or suspected to explain the TMA in our patient. In this observation, the patient died during her aerial evacuation and was therefore not given the chance to benefit from plasma exchange as recommended in TTP. In the current context of arboviruses epidemics in Latin America, physicians should be aware of this potentially lethal complication to diagnose it and promptly start adequate treatment.
Conclusion
This case report is a useful reminder that CHIKV infection may be associated with atypical and severe cases. Acquired TTP, a rare life-threatening disease barely associated with acute viral infections is here associated for the first time with an acute CHIKV infection. The presence of thrombocytopenia and anemia (even mild) or atypical neurologic involvement should rise the suspicion of TTP and schizocytes should be searched. Because of frequent rapid clinical degradation, plasmapheresis should be performed immediately when TTP is suspected. This case also illustrates the lethal risk of air flight medical evacuation in case of severe conditions, which is in the frequent situation in the context of the French Overseas Departments.
